Coronary Heart Disease (CHD)NCT07357961
The Effectiveness of a Theory-driven Behavioral Change Intervention on Sedentary Behavior in Individuals With Coronary Heart Disease: A Randomised Controlled Trial
A study testing A theory-driven behavioural change intervention in people with Coronary Heart Disease (CHD), run by Chinese University of Hong Kong.
Trial summary
The objective of this randomised controlled trial is to examine the effectiveness of a theory-driven behavioural change intervention on total sedentary time (primary outcomes), moderate-to-vigorous physical activity time, intention of behavioural change, future time perception, behavioural prepotency, self-regulation… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Coronary Heart Disease (CHD)
- What is being tested?
- A theory-driven behavioural change intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 232 participants
- Where
- No sites listed yet
- Study dates
- 13 Apr 2026to 31 Oct 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adult 18 years old and above
- Diagnosed with coronary heart disease within one year
- Engaged in MVPA less than 150 minutes per week and a minimum of 8 hours total sedentary time per day, both assessed using the Global Physical Activity Questionnaire
- Able to communicate in Cantonese
- Obtained medical clearance for physical activity (no medical contraindications to exercise, including walking)
- Being able to understand and give informed consent
- Having telephone access, text messaging services or WhatsApp
Who cannot join
- Cannot perform brisk walking exercise
- Unable to perform PA independently
- Cognitive impairments, as indicated by an abbreviated mental test score of less than 7
- Currently enrolled in another clinical trial focusing on limiting SB with/without enhancing PA
- Doctor-diagnosed psychiatric illness
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
The objective of this randomised controlled trial is to examine the effectiveness of a theory-driven behavioural change intervention on total sedentary time (primary outcomes), moderate-to-vigorous physical activity time, intention of behavioural change, future time perception, behavioural prepotency, self-regulation capacity, and exercise capacity in individuals with coronary heart disease.
Hypotheses:
Read more
Compared to the participants in the control group, participants in the intervention group will demonstrate:
- Significantly less total sedentary time
- Significantly improved MVPA time,
- Significantly better intention of behavioural change,
- Significantly higher level of behavioural prepotency,
- Significantly enhanced self-regulation capacity, and
- Significantly greater future time perception
- Significantly better exercise capacity at the immediate post-intervention (T1), the 1-month post-intervention (T2), and the 6-month post-intervention (T3).
Participants will:
Participants in the intervention group will participate in a theory-driven behavioural change intervention over three months, comprising four individual face-to-face sessions (45 minutes each) and four individual telephone sessions (20 minutes each), along with the usual care.
Participants in the attention control group will continue to have the usual care, which includes regular follow-up at the cardiac clinic. Education sessions, consisting of information about healthy lifestyles, except physical activity and sedentary behaviour, with the same schedule as the intervention group, will be provided to account for potential attention effects from contacts.
Read the detailed description
Coronary heart disease is a worldwide health problem and a major contributor to disability, with a high prevalence of 315 million cases globally in 2022. Promoting movement behaviours, which are characterised by having an adequate amount of physical activity and replacing sedentary behaviour with physical activity of all intensities, is beneficial for cardiometabolic health and thus secondary prevention. However, reviews of interventional studies indicate that currently available non-pharmacological interventions are effective in increasing the amount of physical activity, yet limited attention is given to the reduction of sedentary behaviour in current cardiac rehabilitation. Therefore, it is imperative to develop an non-pharmacological intervention targeting sedentary behaviour for adults with coronary heart disease based on the synthesised scientific evidence. The design of the theory-driven behavioural change intervention is based on the findings of our published systematic review and the implications of the qualitative study.
This randomised controlled trial evaluate a theory-driven behavioural change intervention for individuals with coronary heart disease. The objective of the study aims to examine the effectiveness of the intervention in reducing total sedentary time (primary outcome) and improving MVPA, behavioural intentions, future time perception, behavioural prepotency, self-regulation capacity, and exercise capacity in a larger sample.
- Conditions
- Coronary Heart Disease (CHD)
- Being tested
- A theory-driven behavioural change intervention, Attentive control group
- Keywords
- sedentary behaviour, movement behaviours
- Medical subject headings
- Coronary Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A theory-driven behavioural change interventionBehavioural
A theory-driven behavioural change intervention is validated by an expert panel including professionals from various fields, such as nurse consultants, a specialty nurse in cardiology, an experienced registered nurse from a cardiac rehabilitation center in a regional hospital, a physiotherapist, and academia, focusing on strengthening intention to change (connected beliefs and temporal valuations), behavioral prepotency, and enhancing the self-regulatory capacity, as guided by the Temporal Self-Regulation Theory, and supplemented with a intervention booklet. The intervention is developed and facilitated by a registered nurse (principal investigator).
Attentive control groupBehavioural
Participants in the attention control group will participate in education sessions consisting of information about healthy lifestyles, except physical activity and sedentary behaviour. Activities match the time and attention dedicated by the intervention group. Activities are designed to have no impact on sedentary behaviour and physical activity.
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | In addition to the usual care, which is the same as the control group, participants allocated to the intervention group will receive a 12-week theory-driven behavioural change intervention. The intervention is structured into eight individual sessions, including four face-to-face sessions (45 minutes each) and four telephone sessions (20 minutes each). Receives: Behavioral: A theory-driven behavioural change intervention |
| Attention controlled Group | Active comparator | Participants in the control group will continue to have the usual care and education sessions, consisting of information about healthy lifestyles, except physical activity and sedentary behaviour. Receives: Behavioral: Attentive control group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Total sedentary time
Total sedentary time (per day) will be measured using the ActiGraph accelerometer (ActiGraph,Pensacola, FL), wGT3X-BT (during participants' waking time over 7 consecutive days, including both weekdays and weekends).
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Secondary outcomes (7)
Moderate-to-vigorous physical activity time
Moderate-to-vigorous physical activity time (per week) will be measured using the ActiGraph accelerometer (ActiGraph, Pensacola, FL), wGT3X-BT (during participants' waking time over seven consecutive days, including both weekdays and weekends).
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Self-regulation capacity
Self-regulation capacity will be measured using the Chinese version of the Brief Self-Control Scale (BSCS).
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Behavioural prepotency
Behavioural prepotency (on both MVPA and SB) will be measured using the Chinese version of the Self-Reported Behavioural Automaticity Index (SRBAI).
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Future time perception
Future time perception will be measured using the Chinese version of the Consideration of Future Consequences Scale (CFCS-14).
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Intention of behavioural change
Intention of behavioural change will be measured using three questions, including (1) I intend to ...; (2) I plan to ...; and (3) It is likely that I will ... Specifically, questions such as "I intend to do at least 150 minutes of MVPA in the coming week" and "I intend to engage in less than 8 hours of total sedentary time per day in the coming week" will be asked, and participants will respond on a 7-point Likert scale ranging from "strongly disagree" to "strongly agree." The sum average will be calculated. Higher scores represent higher intention.
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Functional exercise capacity
Functional exercise capacity will be measured using Six-Minute Walk Test, a exercise test that refletsfunctional capacity in daily activity. The test was conducted in a flat, straight, indoor corridor of 30 meters. Participants were instructed to walk back and forth along the corridor, covering as much distance as possible within six minutes, at a self-selected pace, with the option to slow down or rest if necessary. Standardized encouragement was provided at regular intervals. The total distance walked (Six-Minute Walk Distance), measured in meters, was recorded. Heart rate, oxygen saturation, blood pressure, and perceived exertion were monitored before and immediately after the test to ensure participant safety.
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Waist circumference
Waist circumference will be measured twice at the midpoint between the last rib and the iliac crest. The increased waist circumference correlates with greater visceral adiposity and increased cardiometabolic risk.
Measured: Pre-intervention, post-intervention (within 1 week immediately after intervention), and at 1-month and 6-month follow-ups.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jan 2026
- Study start13 Apr 2026 (estimated)
- Primary completion31 Oct 2026 (estimated)
- Study completion31 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Coronary Heart Disease (CHD)Studies of the same condition, open and under way.
- More trials run by Chinese University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The intervention is guided by the Temporal Self-Regulation Theory.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 232 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Chinese University of Hong Kong
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elaine Yi Ning Miu, Chinese University of Hong Kong
- Investigators
- Elaine Yi Ning Miu, MSc, Principal investigator, Chinese University of Hong KongHo Yu Cheng, PhD, Study director, Chinese University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07357961
- Sponsor's protocol ID
- CREC_2025.458
- Status last verified
- Jan 2026
- First submitted
- 14 Jan 2026
- Last updated
- 23 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The research team does not have plans to proactively or automatically make the individual participant data (IPD) from this study available to other researchers. However, the IPD may be shared upon request, provided that the requesting party has a valid scientific or medical rationale and obtains the necessary approval from the research team. Any requests for access to the study's IPD will be reviewed on a case-by-case basis by the research team. Factors that will be considered in evaluating such requests include: Scientific merit and validity of the proposed use of the data Qualifications and track record of the requesting researcher or research team Alignment with the original study objectives and participants' consent